Luis Manzano Espinosa-rekin lankidetzan egindako argitalpenak (8)

2023

  1. Conduction system pacing and atrioventricular node ablation in heart failure: The PACE-FIB study design

    ESC Heart Failure, Vol. 10, Núm. 6, pp. 3700-3709

  2. Optimization of Patient Pathway in Heart Failure with Reduced Ejection Fraction and Worsening Heart Failure. Role of Vericiguat

    Patient Preference and Adherence, Vol. 17, pp. 839-849

2022

  1. Challenges in managing patients with heart failure with reduced ejection fraction

    Revista Espanola de Cardiologia Suplementos, Vol. 22, Núm. SB, pp. 1-7

  2. Vericiguat in heart failure: from scientific evidence to clinical practice

    Revista Clinica Espanola

  3. Vericiguat in heart failure: from scientific evidence to clinical practice

    Revista Clinica Espanola, Vol. 222, Núm. 6, pp. 359-369

  4. Vericiguat: VICTORIA trial results

    Revista Espanola de Cardiologia Suplementos, Vol. 22, Núm. SB, pp. 15-22

2020

  1. Myocardial injury determination improves risk stratification and predicts mortality in covid-19 patients

    Cardiology Journal, Vol. 27, Núm. 5, pp. 489-496

2013

  1. Edoxaban versus warfarin in patients with atrial fibrillation

    New England Journal of Medicine, Vol. 369, Núm. 22, pp. 2093-2104